Evidence map›Paper›PMID 37583883›Full record

ArticleFrontiers in public health2023

Stakeholders' views and experiences on implementing new diagnostics in primary care to support management of community-acquired acute respiratory tract infections: a qualitative study.

Melanie Eugenie Hoste, Elien Colman, Marta Wanat, Gail Hayward, Jean-Louis Tissier, Maarten Postma, Herman Goossens, Sibyl Anthierens, Sarah Tonkin-Crine, VALUE-Dx study team

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Transformative impact of point-of-care testing in critical care.World journal of critical care medicine · 2025
    Article
  4. Implementing in-vitro diagnostic point-of-care tests in community health care: how can we make this work?The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Melanie Eugenie HosteDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Elien ColmanDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Marta WanatNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Gail HaywardNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Jean-Louis TissierbioMérieux, Marcy l'Etoile, France.
Maarten PostmaUnit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Herman GoossensLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Sibyl AnthierensDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Sarah Tonkin-CrineNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
VALUE-Dx study team
University of Antwerp · BEUniversity of Oxford · GBUniversity Medical Center Groningen · NLbioMérieux (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The majority of antibiotics are prescribed in primary care for respiratory tract infections. Point-of-care tests (POCTs) for the management of community-acquired acute respiratory tract infections (CA-ARTI) have been developed to help optimize antibiotic prescribing. While some countries in Europe have adopted these tests in primary care settings, most have not. Stakeholders, such as policy-makers, regulators, the diagnostic industry, and scientific associations, have roles in the implementation of new diagnostics in primary care. The aim of this study is to explore these stakeholders' views and experiences, and identify areas of unmet need relating to POCT implementation. Methods: Stakeholders were recruited using purposive sampling and snowballing. Between March 2021 and May 2022, semi-structured interviews were conducted online with stakeholders in Belgium, the UK and from European Union (EU) -level organizations. Interviews were audio recorded and transcribed verbatim. Transcripts were analysed inductively and deductively using thematic analysis. Results: Twenty-six stakeholders participated: eleven from EU-level organizations, seven from Belgium, and eight from the UK. Five themes were identified. Stakeholders felt a balance of top-down and bottom-up approaches were an optimal strategy to the implementation of POCTs. Stakeholders stressed the need to engage with clinicians to act as champions for tests to help raise awareness and generate new evidence on how tests are used. While acknowledging the potential of POCTs for improving patient outcomes and impacting antibiotic prescribing behavior, some raised concerns on how tests would be used in practice and wished to see national data on effectiveness. COVID-19 catalyzed the use of tests, but stakeholders were pessimistic that processes for approving diagnostics during the pandemic would be replicated in the future. Conclusion: Stakeholders provided recommendations for research and practice. Robust reimbursement policies could alleviate financial burden from clinicians and patients, encouraging practices to adopt POCTs. Industry is likely to benefit from engaging as early on as possible with other stakeholders. Due to uncertainty among stakeholders on the impact of POCTs on antibiotic prescribing, further evidence is needed to understand how practices adopt POCTs and the implications for stewardship. Monitoring how POCTs are used can inform future guidelines on successful diagnostic implementation.

Indexed as

COVID-19Respiratory Tract InfectionsAnti-Bacterial AgentsCOVID-19 TestingHumansPoint-of-Care TestingPrimary Health CareAnti-Bacterial Agentsantibiotic prescribingEuropepoint-of-care testingprimary carequalitativerespiratory tract infectionsstakeholder

Identifiers

PMID37583883
PMCPMC10425264
OpenAlexW4385410794

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.